New York Times  7 hrs ago  Comment 
The action comes after the New York State attorney general’s office accused GNC and three other major retailers of selling herbal supplements that were fraudulent or contaminated with unlisted ingredients.
Forbes  Mar 14  Comment 
Analytical experts question results from NY attorney general's investigation into herbal supplements made by GNC, Target, Walmart and Walgreens
TheStreet.com  Mar 12  Comment 
NEW YORK (TheStreet) -- Shares of GNC Holdings   are gaining, up 3.41% to $46.72 in early market trading Thursday, after the wellness retailer was upgraded to "overweight" from "equal weight" by analysts at Morgan Stanley this morning. The...
Benzinga  Mar 12  Comment 
TheStreet.com  Mar 12  Comment 
NEW YORK (TheStreet) -- RATINGS CHANGES Alkermes was downgraded at Morgan Stanley to underweight from equal-weight. Twelve-month price target is $61. New products could underperform and the company is facing increased generic competition,...
Market Intelligence Center  Mar 12  Comment 
GNC Holdings Inc. (GNC) presents a trading opportunity that offers a 7.45% return in just 99 days. A covered call on GNC at the $45.00 level expiring on Jun. '15 offers an assigned return rate of 7.45% or 27.47% annualized. This trade offers...
Benzinga  Mar 11  Comment 
GNC Holdings Inc (NYSE: GNC) continued to gain Wednesday after the company released results of independent tests that suggest its products are properly labeled. New York State officials last month released tests that claimed to show products...
Wall Street Journal  Mar 11  Comment 
Outside testing of some GNC Holdings Inc. nutritional supplements found no improper labeling, the retailer said Tuesday.
TheStreet.com  Mar 10  Comment 
NEW YORK (TheStreet) -- Shares of GNC Holdings  are rebounding, up 1.29% to $45.41 in after-hours trading Tuesday, after the wellness retailer said its health products were in full compliance with all regulatory requirements. The company...
TheStreet.com  Mar 10  Comment 
NEW YORK (TheStreet) -- Shares of GNC Holdings Inc. are lower by 5.84% to $46.15 on heavy volume in late morning trading on Tuesday, following New York State Attorney General Eric Schneiderman's announcement of the formation of a coalition of...
Market Intelligence Center  Mar 10  Comment 
MarketIntelligenceCenter.com's patented algorithms have identified an attractive covered-call trade on GNC Holdings Inc. (GNC). Look at the Jun. '15 $47.50 covered call for a net debit in the $45.31 area. This trade has a duration of 101 days....


GNC Holdings, Inc (NYSE:GNC) is a nutritional supplement retailer with more than 7,200 worldwide locations. Each of the company's retail locations sell health and wellness products such as vitamins, minerals, herbal supplements, and diet products. The company sells a large line of products which are sold with the GNC brand name on it.[1]

According to the Nutrition Business Journal, the nutritional supplements industry generated an estimated $28.7B in 2010. It is projected to grow at a Compounded annual growth rate - CAGR of approximately 5.3% until 2015. GNC views the market as being highly fragmented across distributors and producers. GNC believes that this growth and fragmentation provide a significant advantage to a relatively larger operator like GNC.[2]

The company's initial public offering of stock on the NYSE occurred on March 31, 2011. The company offered 22.5M shares each for $16. This was at the midpoint of the $15-$17 initial price range. 6.5M of its 22.5M offered shares were sold by the company's private equity sponsors. This brought the total deal size to $45M. The lead underwriter of the IPO were Goldman Sachs Group (GS), J P Morgan Chase (JPM), Deutsche Bank AG (DB), and Morgan Stanley (MS).[3]

In 2010, GNC reported a total revenue of $1.8B. This was an increase over the 2009 figure of $1.7B. The company's net income in 2010 was $96.6M. This was a 13% decrease from the $111.9 M net income reported for 2009.[4]


  1. GNC S-1/A 2011 PROSPECTUS SUMMARY "Our Company" pg 1
  2. GNC S-1/A 2011 PROSPECTUS SUMMARY "Industry Overview" pg 2
  3. Renaissance Capital - IPO Home "Nutritional supplement retailer GNC prices its IPO at $16, within the range" 31 March 2011
  4. GNC S-1/A 2011 PROSPECTUS SUMMARY "Summary Consolidated Financial Data" pg 12-13
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki